FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero™ Peripheral IVL System
FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero™ Peripheral IVL System
Early-stage medical device company advancing next-generation intravascular lithotripsy (IVL) technology for peripheral artery disease. Received FDA IDE approval for pivotal trial of Artero system.
Pivotal trial enrollment begins
FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero™ Peripheral IVL System
Chief Executive Officer
VP R&D